S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:RSLS

ReShape Lifesciences (RSLS) Stock Price, News & Analysis

$0.18
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.18
$0.20
50-Day Range
$0.15
$0.23
52-Week Range
$0.14
$4.10
Volume
755,418 shs
Average Volume
480,659 shs
Market Capitalization
$2.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

ReShape Lifesciences MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
4,238.4% Upside
$8.00 Price Target
Short Interest
Healthy
2.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of ReShape Lifesciences in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.08 out of 5 stars

RSLS stock logo

About ReShape Lifesciences Stock (NASDAQ:RSLS)

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

RSLS Stock Price History

RSLS Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
ReShape Lifesciences Inc (RSLS)
ReShape Lifesciences, Inc.
ReShape Lifesciences Inc.
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?
A Preview Of Reshape Lifesciences's Earnings
See More Headlines
Receive RSLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReShape Lifesciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2020
Today
3/28/2024
Next Earnings (Estimated)
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:RSLS
CUSIP
29365M20
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+4,238.4%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-46,210,000.00
Net Margins
-266.76%
Pretax Margin
-267.11%

Debt

Sales & Book Value

Annual Sales
$11.24 million
Book Value
$7.05 per share

Miscellaneous

Free Float
13,122,000
Market Cap
$2.42 million
Optionable
Not Optionable
Beta
0.19
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives


RSLS Stock Analysis - Frequently Asked Questions

What is ReShape Lifesciences' stock price target for 2024?

0 Wall Street analysts have issued 12-month price objectives for ReShape Lifesciences' stock. Their RSLS share price targets range from $8.00 to $8.00. On average, they anticipate the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 4,238.4% from the stock's current price.
View analysts price targets for RSLS
or view top-rated stocks among Wall Street analysts.

How have RSLS shares performed in 2024?

ReShape Lifesciences' stock was trading at $0.2497 at the beginning of 2024. Since then, RSLS shares have decreased by 26.2% and is now trading at $0.1844.
View the best growth stocks for 2024 here
.

Are investors shorting ReShape Lifesciences?

ReShape Lifesciences saw a decline in short interest in March. As of March 15th, there was short interest totaling 428,700 shares, a decline of 43.3% from the February 29th total of 756,200 shares. Based on an average trading volume of 996,600 shares, the days-to-cover ratio is presently 0.4 days. Currently, 2.1% of the company's shares are short sold.
View ReShape Lifesciences' Short Interest
.

When is ReShape Lifesciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our RSLS earnings forecast
.

How were ReShape Lifesciences' earnings last quarter?

ReShape Lifesciences Inc. (NASDAQ:RSLS) released its quarterly earnings data on Thursday, August, 13th. The medical device company reported ($8.67) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($218,400.00) by $218,391.33. The medical device company earned $1.70 million during the quarter. ReShape Lifesciences had a negative net margin of 266.76% and a negative trailing twelve-month return on equity of 492.62%.

When did ReShape Lifesciences' stock split?

ReShape Lifesciences shares reverse split on the morning of Thursday, December 22nd 2022. The 1-50 reverse split was announced on Thursday, December 22nd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 22nd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of ReShape Lifesciences?

Shares of RSLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RSLS) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners